Prof. ÖNDER ARSLAN

Publication Network

Published journal articles indexed by SCI, SSCI, and AHCI

Activity of venetoclax in patients with relapsed or refractory chronic lymphocytic leukaemia: analysis of the VENICE-1 multicentre, open-label, single-arm, phase 3b trial

Kater A. P., ARSLAN Ö., Demirkan F., Herishanu Y., Ferhanoglu B., Diaz M. G., et al.

The Lancet Oncology , vol.25, no.4, pp.463-473, 2024 (SCI-Expanded)

Allogeneic Hematopoietic Stem Cell Transplantation for Primary Myelofibrosis: A 20-year Experience in a Single Center

CENGİZ SEVAL G., Civriz Bozdag S., TOPRAK S. K., Kurt Yuksel M., TOPÇUOĞLU P., ARSLAN Ö., et al.

Balkan medical journal , vol.40, no.3, pp.197-204, 2023 (SCI-Expanded)

Outcomes of Autologous Stem Cell Transplantation as a Consolidative Strategy for the Treatment of Primary and Isolated Secondary Central Nervous System Diffuse Large B Cell Lymphomas

Sahin U., Gokmen A., Soydan E., Urlu S. M., Merter M., Gokgoz Z., et al.

Clinical Lymphoma, Myeloma and Leukemia , vol.23, 2023 (SCI-Expanded)

Gemcitabine, Cisplatin, and Dexamethasone as a Salvage and Mobilization Chemotherapy Before Autologous Stem Cell Transplantation is Effective and Safe Outpatient Regimen in Relapsed and Refractory Hodgkin Lymphoma Patients

Gokmen A., Sahin U., Soydan E., Gokgoz Z., Okcu M. K., Ozan U., et al.

Clinical Lymphoma, Myeloma and Leukemia , vol.22, no.10, 2022 (SCI-Expanded)

Pretransplant Consolidation Therapies Improve the Outcome of Myeloablative Allogeneic Transplantation in Adults with Ph-negative Acute Lymphoblastic Leukemia

Ozdemir Z. N., Kircali E., Şahin U., Seval G., Bozdağ S. C., Toprak S. K., et al.

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , vol.22, no.8, pp.596-600, 2022 (SCI-Expanded)

Alpha-1-Antitrypsin Experience for Steroid-Resistant Acute Graft-Versus-Host Disease

KOYUN D., CENGİZ SEVAL G., Kircali E., CİVRİZ BOZDAĞ S., TOPRAK S. K., TOPÇUOĞLU P., et al.

INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION , vol.38, no.3, pp.601-605, 2022 (SCI-Expanded)

Highlighting the Prognostic Importance of Measurable Residual Disease Among Acute Myeloid Leukemia Risk Factors

Ozdemir Z. N., Sahin U., DALVA K., BALTACI M. A., Uslu A., Ozturk C., et al.

TURKISH JOURNAL OF HEMATOLOGY , vol.38, no.2, pp.111-118, 2021 (SCI-Expanded)

Melphalan pharmacokinetics and transplant related toxicity during autologous stem cell transplantation

Sahin U., Soydan E., Gokmen A., ÖZCAN M., ARSLAN Ö.

BONE MARROW TRANSPLANTATION , vol.56, no.1, pp.7-8, 2021 (SCI-Expanded)

Extracorporeal photochemotherapy in mycosis fungoides

Atilla E., Atilla P. A., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPRAK S. K., Topcuoglu P., et al.

TRANSFUSION CLINIQUE ET BIOLOGIQUE , vol.24, no.4, pp.454-457, 2017 (SCI-Expanded)

A Randomized Comparison of Hemoglobin Content-Based Versus Standard (Unit-Based) Red Blood Cell Transfusion Policy

ATİLLA E., Toprak S. K., civriz bozdag s., TOPÇUOĞLU P., Arslan Ö.

Turkish Journal of Hematology , vol.34, no.3, pp.244-249, 2017 (SCI-Expanded)

Therapeutic plasma exchange in the treatment of neuroimmunologic disorders: review of 50 cases.

Yucesan C., Arslan Ö., Arat M., Yucemen N., Ayyildiz E., Ilhan O., et al.

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis , vol.36, no.1, pp.103-7, 2007 (SCI-Expanded)

Tuberculosis in stem cell transplant patients

Akan H., Arslan Ö., Akan O.

JOURNAL OF HOSPITAL INFECTION , vol.62, no.4, pp.421-426, 2006 (SCI-Expanded) Sustainable Development

Electronic crossmatching

Arslan Ö.

TRANSFUSION MEDICINE REVIEWS , vol.20, no.1, pp.75-79, 2006 (SCI-Expanded)

Haemovigilance in developing countries

Arslan Ö.

HEMATOLOGY , vol.10, pp.79-81, 2005 (SCI-Expanded)

Articles Published in Other Journals

KOYUN D., ATEŞAĞAOĞLU B., YÜKSEL S., SEVAL G. C., BOZDAĞ S. C., TOPRAK S. K., et al.

Türkiye'de Lösemi Lenfoma Miyelom Araştırmaları , vol.8, no.3, pp.86-91, 2024 (Peer-Reviewed Journal)

URLU S. M., ŞAHİN U., GÖKMEN A., ARSLAN Ö., ÖZCAN M.

Türkiye'de Lösemi Lenfoma Miyelom Araştırmaları , vol.8, no.3, pp.92-97, 2024 (Peer-Reviewed Journal)

Lenfoplazmasitik Lenfomada Yeni Nesil Dizileme Yöntemiyle Mutasyon İncelemesinin Tanı ve Tedavi Planında Yeri

KOYUN D., YÜKSEL S., Cengiz Seval G., CİVRİZ BOZDAĞ S., Toprak S. K., Topcuoglu P., et al.

Türkiye'de Lösemi Lenfoma Miyelom Araştırmaları , vol.8, no.1, pp.39-45, 2024 (Peer-Reviewed Journal)

Vitamin D Gene Polymophism in Patients with Aseptic Necrosis after Allogeneic Hematopoietic Stem Cell Transplantation

Soydan E., Sahin U., Ceylaner S., gökmen a., Dogan H., Kurdal Okcu M., et al.

Türkiye'de Lösemi Lenfoma Miyelom Araştırmaları , vol.7, no.2, pp.51-56, 2023 (Peer-Reviewed Journal)

İkinci Allojenik Kök Hücre Nakli: Gerçek Yaşam Verisi

KIRCALI E., CENGİZ SEVAL G., ÖZTÜRK C., YILMAZ H., ŞENOYMAK M. C., YAVUZ G., et al.

Türkiye'de Lösemi Lenfoma Miyelom Araştırmaları , vol.6, no.2, pp.50-55, 2022 (Peer-Reviewed Journal)

The Influence of ATG on the Outcomes of Patients With AML at the Time of Unrelated Donor Transplantation

CENGİZ SEVAL G., KIRCALI E., CİVRİZ BOZDAĞ S., TOPÇUOĞLU P., YÜKSEL M., DALVA K., et al.

Ankara Üniversitesi Tıp Fakültesi Mecmuası , vol.74, no.3, pp.337-342, 2021 (Peer-Reviewed Journal)

Relaps Refrakter Hodgkin Lenfomada Brentuksimab Vedotin Kullanımı: Tek Merkez Deneyimi

Koyun D., Cengiz Seval G., Sökmen M., Akkuş E., Atilla E., Civriz Bozdağ S., et al.

Türkiye'de Lösemi Lenfoma Miyelom Araştırmaları , vol.5, no.1, pp.1-4, 2021 (Peer-Reviewed Journal)

Allojeneik kök hücre naklinde Primer ve sekonder graft yetmezliği

ATİLLA E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPRAK S. K., ARSLAN Ö., et al.

Türkiye'de Lösemi Lenfoma Miyelom Araştırmaları , vol.5, 2021 (Peer-Reviewed Journal)

The Efficacy of Therapeutic Thrombocytapheresis in Patients with Thrombocytosis

NARLI ÖZDEMİR Z., ŞAHİN U., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPRAK S. K., TOPÇUOĞLU P., et al.

Ankara Üniversitesi Tıp Fakültesi Mecmuası , vol.74, 2021 (Peer-Reviewed Journal)

Myelodisplastik Sendromda Allojeneik Kök Hücre Nakli

ATACA ATİLLA P., ATİLLA E., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., TOPÇUOĞLU P., et al.

Ankara Üniversitesi Tıp Fakültesi Mecmuası , vol.73, no.2, pp.113-117, 2020 (Peer-Reviewed Journal)

Safety and Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Mycosis Fungoides and Sezary Syndrome: A 7-year Tertiary Center Analysis

CENGİZ SEVAL G., ATİLLA E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., et al.

Türkiye'de Lösemi Lenfoma Miyelom Araştırmaları , vol.4, no.2, pp.23-27, 2020 (Peer-Reviewed Journal)

The Impact of Pre-transplant Serum Ferritin on Outcomes of Allogeneic Transplantation for Acute Leukemia

ŞAHİN U., ERDAL H., GÜNDÜZ M., MERTER M., NARLI ÖZDEMİR Z., CİVRİZ BOZDAĞ S., et al.

Türkiye'de Lösemi Lenfoma Miyelom Araştırmaları , vol.3, no.1, pp.9-13, 2019 (Peer-Reviewed Journal)

Yoğun Kemoterapi Almış RefrakterHematolojik HastalıklardaHaploidentik Kök Hücre NaklininSağkalıma Etkisİ

YÜKSEL M., DALVA K., ŞAHİN U., KURDALOKCU M., KÖKSAL Ö., GÖKMEN A., et al.

LLM DERGİ , 2017 (Peer-Reviewed Journal)

Refereed Congress / Symposium Publications in Proceedings

NÜKS DİRENÇLİ T HÜCRELİ LENFOMALARDA PRALATREKSAT KULLANIMI: TEK MERKEZ DENEYİMİ

Sönmez G. M., Cengiz Seval G., Yüksel M., Topçuoğlu P., Arslan Ö., Özcan M., et al.

50.Ulusal Hematoloji Kongresi, Antalya, Turkey, 29 October - 02 November 2024, pp.152-153

MİKOSİZ FUNGOİDES VE SEZARY SENDROMLU HASTALARDA BRENTUXİMAB VEDOTİN TEDAVİSİNİN UZUN DÖNEM SONUÇLARI

Yüksel M., Şanlı H., Dalva K., Cengiz Seval G., Topçuoğlu P., Arslan Ö., et al.

50.Ulusal Hematoloji Kongresi, Antalya, Turkey, 29 October - 02 November 2024, pp.111

HİPEREOZİNOFİLİK SENDROM ALT TİPLERİNDE TANI VE TEDAVİ: RETROSPEKTİF TEK MERKEZLİ ÇALIŞMA

Yüksel M., Arslan Ö., Cengiz Seval G., Bektaş M., Demirer T., Toprak S. K.

50.Ulusal Hematoloji Kongresi , Antalya, Turkey, 29 October - 02 November 2024, pp.120

PAROKSİSMAL NOKTURNAL HEMOGLOBİNÜRİ TANILI HASTALARIN DEĞERLENDİRMESİ, TEK MERKEZLİ ÇALIŞMA

Bektaş M., Cengiz Seval G., Toprak S. K., Topçuoğlu P., Özcan M., Arslan Ö., et al.

50.Ulusal Hematoloji Kongresi, Antalya, Turkey, 29 October - 02 November 2024, pp.209

MANTLE HÜCRELİ LENFOMA TANILI HASTALARDA İBRUTİNİB KULLANIMI: TEK MERKEZ DENEYİMİ

Yüksel M., Toprak S. K., Cengiz Seval G., Arslan Ö., Özcan M., Topçuoğlu P.

50.Ulusal Hematoloji Kongresi, Antalya, Turkey, 29 October - 02 November 2024, pp.113

GÜNCEL KLAVUZLAR EŞLİĞİNDE KLİNİKTE MASTOSİTOZ: TEK MERKEZ DENEYİMİ

AYDOĞAN M., CENGİZ SEVAL G., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., ÖZCAN M., et al.

50.Ulusal Hematoloji Kongresi, 29 October - 02 November 2024

PERİFERİK T HÜCRELİ LENFOMA TANILI HASTALARIN ANALİZİ: TEK MERKEZ DENEYİMİ

YÜKSEL M., DEMİR C. K., CENGİZ SEVAL G., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., et al.

50.Ulusal Hematoloji Kongresi, 29 October 2024

Prognostic evaluation of PET/CT in residual post-chemotherapy +/- RT masses in patients with Hodgkin Lymphoma and its impact on survival

BEKTAŞ M., KAR İ., CENGİZ SEVAL G., TOPRAK S. K., TOPÇUOĞLU P., ÖZCAN M., et al.

11TH AEGEAN HEMATOLOGY ONCOLOGY SYMPOSIUM, 19 - 22 September 2024

KRONİK LENFOSİTİK LÖSEMİLERDE İMMUNGLOBULİN GENLERİ VARYANT ALT TİPLERİ, ALT KLONLAR İLE SOMATİK HİPERMUTASYON İLE HASTALIK BİYOLOJİSİNİN İLİŞKİSİ

Aygün R. Ş., Yüksel S., Örüncü M. B., Yüksel M., Cengiz Seval G., Arslan Ö., et al.

49. Ulusal Hematoloji Kongresi , Antalya, Turkey, 1 - 05 November 2023, pp.148-149

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN RELAPS/REFRACTORY LYMPHOMA PATIENTS: A SINGLE CENTER EXPERIENCE

Karakaya B., Yilmaz H., Ermis G. Y., Cengiz Seval G., Bozdag S. C., Toprak S. K., et al.

49th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, ELECTR NETWORK, 23 - 26 April 2023, pp.457-458

ALPHA-1-ANTITRYPSIN EXPERIENCE FOR STEROID-RESISTANT ACUTE GRAFT-VERSUS-HOST DISEASE

Koyun D., Cengiz Seval G., Bozdag S. C., Toprak S. K., Topçuoğlu P., Özcan M., et al.

49th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, ELECTR NETWORK, 23 - 26 April 2023, pp.301-302

EXTERNAL VALIDATION OF THREE EXISTING EARLY MYELOMA RELAPSE SCORES (BY EBMT, CIBMTR, AND GIMEMA) IN A SINGLE CENTER SHOWS MAJOR DIFFERENCES

Beksaç M., Cengiz Seval G., Civriz Bozdağ S., Toprak S. K., Yüksel M., Topçuoğlu P., et al.

The 49th Annual Meeting of the European Society for Blood and Marrow Transplantation: Physicians, Paris, France, 23 April 2023, vol.58, pp.107

P19 EXTERNAL VALIDATION OF THREE EXISTING EARLY MYELOMA RELAPSE SCORES (BY EBMT, CIBMTR, AND GIMEMA) IN A SINGLE CENTER SHOWS MAJOR DIFFERENCES

BEKSAÇ M., CENGİZ SEVAL G., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., TOPÇUOĞLU P., et al.

The 49th Annual Meeting of the European Society for Blood and Marrow Transplantation, France, 23 April 2023

The Impact of CD34+Cell and Immunefector Cell Dose on Transplant Outcomes

Koyun D., Cengiz Seval G., Bozdag S. C., Toprak S. K., Topçuoğlu P., Özcan M., et al.

64th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Louisiana, United States Of America, 10 - 13 December 2022, vol.140, pp.12673-12674

Single Center Real World Data That Compares Autologous Stem Cell Transplant in the Era of Anti-CD38 Monoclonal Antibody Based Treatments for AL Amyloidosis

Yilmaz H., Cengiz Seval G., Karakaya B., Yavuz G., Aydogan M., Bozdag S. C., et al.

64th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Louisiana, United States Of America, 10 - 13 December 2022, vol.140, pp.4369-4370

Prophylactic defibrotide is effective for acute graft versus host disease as well as sinusoidal obstructive syndrome

KIRCALİ E., CENGİZ SEVAL G., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., et al.

48th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), United States Of America, 19 - 22 March 2022

GRAFT VERSUS HOST HASTALIĞI PROFİLAKSİSİNDE ATG VE POST CY KULLANIMININ NAKİL SONUÇLARINA ETKİSİ: TEK MERKEZ DENEYİMİ

Karakaya B., ŞAHİN Y. İ., MAMMADLI H., Yavuz G., CENGİZ SEVAL G., CİVRİZ BOZDAĞ S., et al.

14. Ulusal kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, 10 March 2022

THE OUTCOME OF AUTOLOGOUS HEMATOPOIETIC CELL TRANSPLANTATION IN ELDERLY PATIENTS WITH AGGRESSIVE NON-HODGKIN LYPHOMA

İLHAN O., CENGİZ SEVAL G., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., TOPÇUOĞLU P., et al.

63TH ASH CONGRESS, ATLANTA, United States Of America, 8 - 11 December 2021

The Outcome of Autologous Hematopoietic Cell Transplantation in Elderly Patients with Aggressive Non-Hodgkin Lymphoma

İLHAN O., CENGİZ SEVAL G., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., TOPÇUOĞLU P., et al.

63rd ASH Annual Meeting and Exposition, 11 December 2021

T/B LENFOBLASTİK LENFOMA TANILI HASTALARIN YENİ TEDAVİLER IŞIĞINDA RETROSPEKTİF DEĞERLENDİRİLMESİ

Karakaya B., Akbulut H., Öztürk C., Koyun D., Kırcalı E., Yilmaz H., et al.

47. Ulusal Hematoloji Kongresi , Antalya, Turkey, 4 - 07 November 2021, pp.178-179

AKUT PROMİYELOSİTİK LÖSEMİ TANILI HASTALARIN KLİNİK ÖZELLİKLERİ VE TEDAVİ SONUÇLARI: TEK MERKEZ DENEYİMİ

Yavuz Ermiş G., Yilmaz H., Özütemiz S., Selvi N., Öztürk C., Kırcalı E., et al.

47. Ulusal Hematoloji Kongresi , Antalya, Turkey, 4 - 07 November 2021, pp.202-204

HODGKİN LENFOMA TANILI HASTALARDA EKSTRANODAL TUTULUM VE YENİ TEDAVİLER

Yavuz Ermiş G., Yilmaz H., Özütemiz S., Selvi N., Öztürk C., Kırcalı E., et al.

47. Ulusal Hematoloji Kongresi , Antalya, Turkey, 4 - 07 November 2021, pp.346-347

PROFLAKTİK DEFİBROTİD SOS DIŞINDA AKUT GRAFT VS HOST HASTALIĞINDA DA ETKİN

KIRCALI E., CENGİZ SEVAL G., ÖZTÜRK C., YILMAZ H., Yavuz G., Karakaya B., et al.

47. Ulusal Hematoloji Kongresi, 04 November 2021

RELAPS/ REFRAKTER HODGKİN LENFOMA HASTALARINDA ALLOJENİK HEMATOPOETİK KÖK HÜCRE NAKLİ: TEK MERKEZ DENEYİMİ

Koyun D., Şahin U., Cengiz Seval G., Civriz Bozdağ S., Toprak S. K., Yüksel M., et al.

13. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, Antalya, Turkey, 2 - 03 April 2021, no.52, pp.104-105

ALLOJENİK KÖK HÜCRE NAKLİ HASTALARINDA PERİTRANSPLANT METRONİDAZOL KULLANIMIYLA AKUT GVHD RİSKİNİN İLİŞKİ

KIRCALI E., CENGİZ SEVAL G., ÖZTÜRK C., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., et al.

13. Ulusal kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, 02 April 2021

MULTİPL MİYELOMDA OTOLOG PRİFERİK KÖK HÜCRE NAKLİ SONRASI ERKEN NÜKSÜ BELİRLEMEDE CIBMTR, ISS VE R-ISS SKORLAMA SİSTEMLERİNİN KARŞILAŞTIRILMASI

CENGİZ SEVAL G., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., et al.

13. Ulusal kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, 02 April 2021

Relaps/Refrakter Hodgkin Lenfoma Hastalarında Allojenik Hematopoetik Kök Hücre Nakli: Tek Merkez Deneyimi

KOYUN D., ŞAHİN U., SEVAL G. C., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M. K., et al.

13. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, 2 - 03 April 2021

KAN GRUBU UYUŞUMSUZLUĞUNUN HAPLOİDENTİK TRANSPLANT SONUÇLARINA ETKİSİ VE KAN GRUBU DÖNÜŞÜM SÜRECİ

GÖKGÖZ M., ŞAHİN U., GÖKMEN A., SOYDAN E., CENGİZ SEVAL G., ARSLAN Ö., et al.

13. Ulusal kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, 02 April 2021

THE IMPACT OF PRETRANSPLANT IMMUNOMODULATORY DRUGS ON CMV REACTIVATION

YÜKSEL M., CENGİZ SEVAL G., USLU A., KIRCALI E., KOYUN D., Yavuz G., et al.

8 45 th International Congress on Leukemia Lymphoma Myeloma, Ankara, Turkey, 21 May 2021, vol.38, no.71, pp.1-81

PATIENT RELATED FACTORS OVERRIDE LENALIDOMIDE MAINTENANCE AS A FACTOR OF SEVERITY FOR COVID-19 INFECTION

KIRCALI E., CENGİZ SEVAL G., TOPRAK S. K., TOPÇUOĞLU P., ARSLAN Ö., ÖZCAN M., et al.

8th International Congress on Leukemia Lymphoma Myeloma, Ankara, Turkey, 21 May 2021, vol.38, pp.50 Sustainable Development

MYELOPROLİFERATİF NEOPLAZİDE PEG-IFN-α-2A ETKİNLİK VE GÜVENİLİRLİĞİ: TEK MERKEZ RETROSPEKTİF GERÇEK YAŞAM ÇALIŞMASI

Koyun D., Cengiz Seval G., Civriz Bozdağ S., Toprak S. K., Topçuoğlu P., Arslan Ö., et al.

46. Ulusal Hematoloji Kongresi , Antalya, Turkey, 28 - 31 October 2020, no.197, pp.112

GRAFT VS HOST HASTALIĞINDA ALFA- 1 ANTİTRİPSİN DENEYİMİMİZ

Koyun D., Cengiz Seval G., Kırcalı E., Civriz Bozdağ S., Toprak S. K., Topçuoğlu P., et al.

46. Ulusal Hematoloji Kongresi , Antalya, Turkey, 28 - 31 October 2020, no.283, pp.117-118

FOLİKÜLER LENFOMADA BAZAL PET’ TE TOPLAM METABOLİK TÜMÖR HACMİ VE TOPLAM LEZYON GLİKOLİZİNİN PROGNOSTİK ÖNEMİ

Kırcalı E., Cengiz Seval G., Araz M., Uslu A., Öztürk C., Koyun D., et al.

46. Ulusal Hematoloji Kongresi, Antalya, Turkey, 28 - 31 October 2020, no.278, pp.105

AKUT MYELOBLASTİK LÖSEMİ HASTALARINDA NÜKLEOFOSMİN MUTASYONU MİNİMAL REZİDÜEL HASTALIK TAKİBİNDE YOL GÖSTERİCİMİDİR

CENGİZ SEVAL G., ÖZCAN M., TOPÇUOĞLU P., DEMİRER T., BEKSAÇ M., CİVRİZ BOZDAĞ S., et al.

42.Ulusal Hematoloji Kongresi, Turkey, 28 - 30 October 2020

CD34+ VE İMMUNEFEKTÖR HÜCRE SAYIMININ TRANSPLANTASYON SONUÇLARINA ETKİSİ

Koyun D., Cengiz Seval G., Dalva K., Uslu A., Öztürk C., Kırcalı E., et al.

12. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, Muğla, Turkey, 5 - 07 March 2020, no.159, pp.60-61

Large Granular Lymphocytosis and Its Impact on Long Term Clinical Outcomes Following Allogeneic Hematopoietic Stem Cell Transplantation: 14-Year Follow-up Data

CENGİZ SEVAL G., USLU A., KİRCALİ E., CİVRİZ BOZDAĞ S., DALVA K., TOPRAK S. K., et al.

61st ASH Annual Meeting and Exposition, NY, United States Of America, 7 - 10 December 2019, vol.26, pp.305-306

Effect of Cyclophosphamide on Hemorrhagic Cystitis Following Haploidentical Related Compared to Matched Related/Unrelated Donor Hematopoietic Stem Cell Transplantation: A 7-Year Tertiary Center Analysis

SEVAL G. C., Öztürk n., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., et al.

61st ASH Annual Meeting, 7 - 10 December 2019

Large Granular Lymphocytosis and Its Impact on Long Term Clinical Outcomes Following Allogeneic Hematopoietic Stem Cell Transplantation: 14-Year Follow-up Data

CENGİZ SEVAL G., Uslu A., Kircali E., CİVRİZ BOZDAĞ S., DALVA K., TOPRAK S. K., et al.

61st Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Florida, United States Of America, 7 - 10 December 2019, vol.134

Which One, Generic Vs Original Glivec Is More Effective in Patients with Chronic Myeloid Leukemia?

Kircali E., CENGİZ SEVAL G., CİVRİZ BOZDAĞ S., TOPRAK S. K., Yuksel M. K., ARSLAN Ö., et al.

61st Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Florida, United States Of America, 7 - 10 December 2019, vol.134

Effect of Cyclophosphamide on Hemorrhagic Cystitis Following Haploidentical Related Compared to Matched Related/Unrelated Donor Hematopoietic Stem Cell Transplantation: A 7-Year Tertiary Center Analysis

CENGİZ SEVAL G., Ozturk N., CİVRİZ BOZDAĞ S., Yuksel M. K., TOPÇUOĞLU P., ARSLAN Ö., et al.

61st Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Florida, United States Of America, 7 - 10 December 2019, vol.134

HANGİSİ, ORJİNAL İMATİNİB Mİ JENERİK Mİ KRONİK MYELOİD LÖSEMİDE DAHA ETKİN?

KIRCALI E., CENGİZ SEVAL G., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., ARSLAN Ö., et al.

45. Ulusal Hematoloji Kongresi, 31 October 2019

IMID/PI İÇEREN TEDAVİLERE DİRENÇLİ MM OLGULARINDA POM/LEN İLE BİRLİKTE ELOTUZUMAB TEDAVİSİ KALICI ≥ÇİKY SAĞLAYABİLİR Mİ?

BEKSAÇ M., CENGİZ SEVAL G., PAYDAŞ S., FIRATLI TUĞLULAR T., ARSLAN Ö., GÖKER H., et al.

45. Ulusal Hematoloji Kongresi, Antalya, Turkey, 30 October 2019, pp.168

Elotuzumab Plus Pomalidomide or Lenalidomide is Able to Achieve Durable = Vgpr Responses Among Immunomodulatory/Proteasome Inhibitor Refractory Myeloma Patients: A Report on Multicenter Experience From Turkey

BEKSAÇ M., CENGİZ SEVAL G., PAYDAŞ S., TUĞLULAR A. T., ARSLAN Ö., GÖKER A. H., et al.

17th International Myeloma Workshop, 12 - 15 September 2019

Blood group incompatibility in haplo-identical stem cell transplantation: Favor or unfavorable effect on the erythrocyte recovery?

CENGİZ SEVAL G., Uslu A., TOPRAK S. K., CİVRİZ BOZDAĞ S., YÜKSEL M., ARSLAN Ö., et al.

45th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Frankfurt, Germany, 24 - 27 March 2019, vol.54, pp.368-369

Haploidentical stem cell transplantation may be an option for hematological malignancies in urgent conditions

İLHAN O., CENGİZ SEVAL G., Uslu A., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., et al.

45th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Frankfurt, Germany, 24 - 27 March 2019, vol.54, pp.382

Can the drugs used before autologous hematopoietic stem cell transplantation have impact on CMV reactivation that results in decreased os in myeloma patients after ASCT?

YÜKSEL M., CENGİZ SEVAL G., Uslu A., Kircili E., KOYUN D., Ozturk C., et al.

45th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Frankfurt, Germany, 24 - 27 March 2019, vol.54, pp.505-506

Is mobilization with chemotherapy effect response in the multiple myeloma?

CENGİZ SEVAL G., Uslu A., CİVRİZ BOZDAĞ S., YÜKSEL M., ARSLAN Ö., ÖZCAN M., et al.

45th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Frankfurt, Germany, 24 - 27 March 2019, vol.54, pp.500

Can Nelarabıne Rescue The Graft After Allogeneıc Hematopoıetıc Stem Cell Transplantatıon In T-All ?

YÜKSEL M., CENGİZ SEVAL G., CİVRİZ BOZDAĞ S., TOPRAK S. K., TOPÇUOĞLU P., ARSLAN Ö., et al.

24 Congress of the European Hematology Association, 13 - 16 June 2019

IS AGE AN IMPORTANT FACTOR FOR AUTOLOGOUS PERIPHERAL HEMATOPOIETIC STEM CELL TRANSPLANTATION IN ELDERLY PATIENTS WITH NONHODGKIN LYMPHOMA?

Cengiz Seval G., Uslu A., Civriz Bozdağ S., Toprak S. K., Yüksel M., Topçuoğlu P., et al.

7th International Congress on Leukemia Lymphoma Myeloma, İstanbul, Turkey, 2 - 04 May 2019, pp.47-48

LEUKAPHERESIS REDUCES 4-WEEK MORTALITY IN ACUTE MYELOID LEUKEMIA PATIENTS WITH HYPERLEUKOCYTOSIS - A RETROSPECTIVE STUDY FROM A TERTIARY CENTER

Cengiz Seval G., Uslu A., Civriz Bozdağ S., Toprak S. K., Yüksel M., Topçuoğlu P., et al.

7th International Congress on Leukemia Lymphoma Myeloma, İstanbul, Turkey, 2 - 04 May 2019, pp.37

COMPARISION OF AUTOLOGOUS CONDITIONING REGIMENS AMONG LYMPHOMA PATIENTS

Gokgöz Z., Uğur Bilgin A., Arslan Ö., Özcan M., İlhan O.

7th International Congress on Leukemia Lymphoma Myeloma, İstanbul, Turkey, 2 - 04 May 2019, pp.52

CAN THE DRUGS USED BEFORE AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION (ASCT) HAVE IMPACT ON CMV REACTIVATION THAT RESULTS IN DECREASED OS IN MYELOMA PATIENTS AFTER ASCT?

Yüksel M., Cengiz Seval G., Uslu A., Kırcalı E., Koyun D., Öztürk C., et al.

7th International Congress on Leukemia Lymphoma Myeloma, İstanbul, Turkey, 2 - 04 May 2019, pp.59

SUCCESSFUL TREATMENT OF GRAFT FAILURE WITH SECOND ALLOGENEIC STEM CELL TRANSPLANTATION WITHOUT CONDITIONING REGIMEN

Cengiz Seval G., Uslu A., Öztürk C., Civriz Bozdağ S., Yüksel M., Topçuoğlu P., et al.

8th International Congress on Leukemia Lymphoma Myeloma, İstanbul, Turkey, 2 - 04 May 2019, pp.75

CAN AUTOLOGOUS STEM CELL TRANSPLANTATION ABROGATE THE POOR PROGNOSIS ASSOCIATED WITH HIGH LDH?

Cengiz Seval G., Civriz Bozdağ S., Yüksel M., Topçuoğlu P., Arslan Ö., Özcan M., et al.

7th International Congress on Leukemia Lymphoma Myeloma, İstanbul, Turkey, 2 - 04 May 2019, pp.45

HAPLOIDENTICAL STEM CELL TRANSPLANTATION MAY BE A GOOD ALTERNATIVE AS SALVAGE TREATMENT FOR HEAVILY PRETREATED PATIENTS WITH LEUKEMIA

Cengiz Seval G., Uslu A., Civriz Bozdağ S., Toprak S. K., Yüksel M., Topçuoğlu P., et al.

7th International Congress on Leukemia Lymphoma Myeloma, İstanbul, Turkey, 2 - 04 May 2019, pp.56-57

Pretransplant hemoglobin and serum creatinine levels correlate with progression free survival in myeloma patients undergoing autologous stem cell transplantation.

DEMİRER T., CENGİZ SEVAL G., TOPRAK S. K., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., et al.

Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America, 31 May - 04 June 2019, vol.37

CAN AUTOLOGOUS STEM CELL TRANSPLANTATIONABROGATE THE POOR PROGNOSIS ASSOCIATED WITH HIGHLDH?

SEVAL G. C., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., ÖZCAN M., et al.

7th International Congress on Leukemia Lymphoma Myeloma, 2 - 04 May 2019

retrospective analysis of 149 unselected patıents wıth mantle cell lymphoma confırms prognostic relevance of mıpı: sıngle center ecperıence

CENGİZ SEVAL G., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., ÖZCAN M., et al.

ICLLM 2019, 02 May 2019

HEV seroprevalence in blood donors in Turkey: Comparison of two commercial anti-HEV total Ab ELISA kit

Yasar O., Cengiz G., Karatayli E., Kizilpinar M., Yurdcu E., ALBAYRAK DELİALİOĞLU R., et al.

International Liver Congress / 54th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), Vienna, Austria, 10 - 14 April 2019, vol.70

MULTİPLE MYELOM HASTALARINDA OTOLOG PERİFERİK KÖK HÜCRE NAKLİ ESNASINDA GELİŞEN NÖTROPENİK ATEŞ

Uslu A., Cengiz Seval G., Öztürk C., Narlı Özdemir Z., Kırcalı E., Koyun D., et al.

11. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, Antalya, Turkey, 1 - 02 March 2019, no.142, pp.130

Transplant Sonrası Trombositopenide Eltrombopag: Tek Merkez Deneyimimiz

Kırcali E., Cengiz Seval G., Koyun D., Civriz Bozdağ S., Topçuoğlu P., Özcan M., et al.

11. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, Antalya, Turkey, 1 - 03 March 2019

HAPLOİDENTİK KÖK HÜCRE NAKİLLERİNDE KAN GRUBU UYUMSUZLUĞU: ERİTROSİT ENGRAFTMANI ÜZERİNE ETKİSİ VAR MI?

CENGİZ SEVAL G., USLU A., TOPRAK S. K., CİVRİZ BOZDAĞ S., YÜKSEL M., ARSLAN Ö., et al.

11. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, 01 March 2019

Does Level of Vitamin D Prior to Allogeneic Stem Cell Transplantation Affect the Transplant Outcomes?

Soydan E., Gokmen A., Gokgoz Z., Sen S., Ozkumur K. O., Okcu M. K., et al.

Transplant and Cell Therapy Meeting / Combined Annual Meetings of the American-Society-for-Blood-and-Marrow-Transplantation (ASBMT) and the Center-for-International-Blood-and-Marrow-Transplant-Research (CIBMTR), Texas, United States Of America, 13 - 24 February 2019, vol.25

Influence of Conditioning Regimens with Total Body Irradiation (TBI) on Graft Versus Host Disease and Graft Versus Leukemia Effect Following Donor Lymphocyte Infusions (DLI)

CENGİZ SEVAL G., Atilla E., Ulas B., CİVRİZ BOZDAĞ S., TOPRAK S. K., Yuksel M. K., et al.

Comparision of Outcomes According to HLA Disparity in Acute Leukemia Patients: A Single Cente Institution Experience

TOPÇUOĞLU P., CENGİZ SEVAL G., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., DALVA K., et al.

60th ASH Annual Meeting and Exposition, 01 December 2018

Retrospective Analysis of 149 Unselected Patients with Mantle Cell Lymphoma Confirms Prognostic Relevance of Mantle Cell Lymphoma International Prognostic Index: Single Center Experience

CENGİZ SEVAL G., Ulas B., TAŞCI O., Ozel F., Bulat B., KUZU I., et al.

60th Annual Meeting of the American-Society-of-Hematology (ASH), California, United States Of America, 1 - 04 December 2018, vol.132

Impact of ABO Mismatch on Outcomes of Allogeneic Hematopoietic Stem Cell Recipients: 30 Years of Experience with 1016 Patients

Atilla E., TOPÇUOĞLU P., AKKUŞ E., Atilla P. A., CİVRİZ BOZDAĞ S., YÜKSEL M., et al.

60th Annual Meeting of the American-Society-of-Hematology (ASH), California, United States Of America, 1 - 04 December 2018, vol.132

Donor Lymphocyte Infusions for Relapsed Hematological Malignancies after Allogeneic Hematopoietic Stem Cell Transplantation: Single Center Experience

GÜRMAN G., CENGİZ SEVAL G., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., TOPÇUOĞLU P., et al.

60th Annual Meeting of the American-Society-of-Hematology (ASH), California, United States Of America, 1 - 04 December 2018, vol.132

Akut Miyeloid Lösemide Nakil Öncesi ve Nakil Sonrası +28. Gün Değerlendirilen Minimal Kalıntı Hastalığın Hastalık Seyrine Etkisi

DALVA K., NARLI ÖZDEMİR Z., ŞAHİN U., USLU A., MURADOVA B., CENGİZ SEVAL G., et al.

44. Ulusal Hematoloji Kongresi, Antalya, Turkey, 31 October - 03 November 2018, pp.245-246

ALLOJENİK HEMATOPOİETİK KÖK HÜCRE NAKLİ YAPILAN ALL HASTALARINDA CMV ENFEKSİYONUNUN NAKİL SONUÇLARINA ETKİLERİ

KALACI E., ŞAHİN EROĞLU D., CENGİZ SEVAL G., NARLI ÖZDEMİR Z., BEKSAÇ M., ÖZCAN M., et al.

44. Ulusal Hematoloji Kongresi, Turkey, 31 October - 03 November 2018

ALLOJENİK HEMATOPOİETİK KÖK HÜCRE NAKLİ YAPILANALL HASTALARINDA CMV ENFEKSİYONUNUN NAKİLSONUÇLARINA ETKİLERİ

KALACI E., ŞAHİN EROĞLU D., CENGİZ SEVAL G., NARLI ÖZDEMİR Z., BEKSAÇ M., ÖZCAN M., et al.

44. Ulusal Hematoloji Kongresi, Turkey, 31 October - 03 November 2018

AKUT LÖSEMİ HASTALARINDA HLA UYUŞUMSUZLUĞUNUNNAKİL SONUÇLARINA ETKİSİ: TEK MERKEZ DENEYİMİ

CENGİZ SEVAL G., NARLI ÖZDEMİR Z., TATAR L., SÖKMEN M., CİVRİZ BOZDAĞ S., TOPRAK S. K., et al.

44. Ulusal Hematoloji Kongresi, Turkey, 31 October - 03 November 2018

Comparing Conditioning Regimens for Autologous Stem Cell Transplantation in Lymphoma Patients

CENGİZ SEVAL G., GÖREN ŞAHİN D., SOYDAN E., ÖZÇELİK E. T., GÖKMEN A., GÖKGÖZ Z., et al.

2018 Society of Hematologic Oncology (SOHO) Annual Conference, 12 - 15 September 2018

BCNU-EAM vs non-BCNU alternative alkylator -EAM conditioning regimens for autologous stem cell transplantation in lymphoma patients

Sahin D. G., Cengiz G. S., Soydan E., Ozcelik E. T., Gokmen A., Gokgoz Z., et al.

44th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Lisbon, Portugal, 18 - 21 March 2018, vol.53, pp.256-257

Is post-transplant albumin a predictor of early transplant complications?

TOPÇUOĞLU P., CENGİZ SEVAL G., AKKUŞ E., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., et al.

44th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Lisbon, Portugal, 18 - 21 March 2018, vol.53, pp.344-345

Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation with Different Doses of Antithymocyte Globulin Containing Conditioning in Hematological Malignancies

Gokgoz Z., Soydan E., Gokmen A., ARSLAN Ö., İLHAN O., ÖZCAN M.

44th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Lisbon, Portugal, 18 - 21 March 2018, vol.53, pp.284-285

Haploidentical transplantation does not have survival advantage over unrelated donor transplantation in haematological diseases

Soydan E., Gokmen A., Gokgoz Z., İLHAN O., ARSLAN Ö., ÖZCAN M.

44th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Lisbon, Portugal, 18 - 21 March 2018, vol.53, pp.747

Retrospective Analysis Learn Conditioning for Autologous Stem Cell Transplantation

Soydan E., Gokmen A., Gokgoz Z., İLHAN O., ARSLAN Ö., ÖZCAN M.

Blood and Marrow Transplantion Tandem Meetings of the Center-for-International-Blood-and-Marrow-Transplant-Research (CIBMTR) / American-Society-for-Blood-and-Marrow-Transplantation (ASBMT), Utah, United States Of America, 21 - 25 February 2018, vol.24

MYELOFİBROZİSTE ALLOJENEİK HEMATOPOETİK KÖK HÜCRE NAKLİ SONUÇLARI: TEK MERKEZ DENEYİMİ

CENGİZ SEVAL G., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., et al.

10. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, 01 March 2018

AKUT GRAFT VERSUS HOST HASTALIĞI KLİNİK SONUÇLARI: TEK MERKEZ DENEYİMİ

NARLI ÖZDEMİR Z., CENGİZ SEVAL G., USLU A., ÖZTÜRK C., CİVRİZ BOZDAĞ S., TOPRAK S. K., et al.

10. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, Antalya, Turkey, 01 March 2018

KEMOTERAPİ İLE MOBİLİZASYON MULTİPL MİYELOMDA YANITLARI ETKİLİYOR MU?

CENGİZ SEVAL G., USLU A., CİVRİZ BOZDAĞ S., YÜKSEL M., ARSLAN Ö., ÖZCAN M., et al.

10. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, 01 March 2018

Age is Not an Important Factor for Autologous Peripheral Hematopoietic Stem Cell Mobilization and Collection in Patients with Multiple Myeloma

İLHAN O., CENGİZ SEVAL G., TOPRAK S. K., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., et al.

Mesenchymal Stem Cell Infusion in Haploidentical Hematopoietic Stem Cell Transplantation in Patients with Hematological Malignancies

Arslan Ö., Elçin A. E., Atilla E., Seker Ş., Baydın P., Gunduz M., et al.

Age Is Not Important for Autologous Peripheral Hematopoietic Stem Cell Transplantation in Multiple Myeloma

Ilhan O., CENGİZ SEVAL G., TOPRAK S. K., Topcuoglu P., Ozel F., CİVRİZ BOZDAĞ S., et al.

59th Annual Meeting of the American-Society-of-Hematology (ASH), Georgia, United States Of America, 9 - 12 December 2017, vol.130

Dilemma-High Response Rates Vs High Toxicity: Autologous Stem Cell Transplantation for Lymphoma

Atilla E., TOPRAK S. K., CİVRİZ BOZDAĞ S., YÜKSEL M., Topcuoglu P., Akan H., et al.

59th Annual Meeting of the American-Society-of-Hematology (ASH), Georgia, United States Of America, 9 - 12 December 2017, vol.130

Kronik Myeloproliferatif Neoplazilerde Kalretikulin (CALR) mutasyonu

Öztekin Ş., ÖCAL E., Boyacıgil Ş., ÖZCAN M., BEKSAÇ M., ARSLAN Ö., et al.

Ulusal Hematoloji Kongresi, Turkey, 31 October - 04 November 2017

Old gene new phenotype: ADA2 deficiency

KOSTEL BAL S., SAHİN U., JIMENEZ HEREDİA R., ROMANO F., KAYGUSUZ G., AZZARI C., et al.

ESID 2017, 11 - 14 September 2017

ALLOEGENEİC HEMATOPOİETİC STEM CELL TRANSPLANTATİON İN ADVANCED AGE ADULTS:İS İT POSSİBLE TO TRANSPLANT SAFELY?

ATİLLA E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPRAK S. K., AKAN H., et al.

ebmt2017, 26 - 29 March 2017

The outcome of haploidentical stem cell transplantation

ATİLLA E., bilgiç e., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPRAK S. K., TOPÇUOĞLU P., et al.

ebmt 2017, 22 - 25 June 2017

A biosimilar G-CSF filgrastim is as effective as refrence drug however it is not as cost effective as it supposed to be and by the way no imapct on health care system.

YÜKSEL M., PEKCAN G., ŞAHİN U., CİVRİZ BOZDAĞ S., TOPRAK S. K., TOPÇUOĞLU P., et al.

43rd Annual Meeting of the European Society for Blood and Marrow Transplantation, Marseille, France, 26 - 29 March 2017

REAL WORLD DATA IN RELAPSED REFRACTORY MYELOMA PATIENTS TREATED WITH CARFILZOMIB, A MULTICENTER EXPERİENCE

SEVİNDİK Ö. G., SOLMAZ Ş. M., PEHLİVAN M., KABUKLU S. H., YALNIZ F. F., ÖZKOCAMAN V., et al.

6.INTERNATIONAL CONGRESS OF LEUKEMIA LYMPHOMA MYELOMA, Antalya, Turkey, 11 - 13 May 2017

Isolation And Culture Of Good Manufacturing Practice Grade Human Bone Marrow Derived Mesenchymal Stem Cells For Clinical Applications

ELÇİN A. E., Şeker Ş., BAYDIN P., DALVA K., PARMAKSIZ M., LALEGÜL Ö., et al.

22nd International Symposium on Biomedical Science & Engineering BIOMED, Ankara, Turkey, 12 May 2017

Real-world data in relapsed refractory myeloma patients with carfilzomib, a multicenter turkish experience

SEVİNDİK Ö. G., medeni solmaz ş., PEHLİVAN M., HACIOĞLU S., YALNIZ F. F., ÖZKOCAMAN V., et al.

6th International Congress on Leukemia-Lymphoma-Myeloma, 11 - 13 May 2017

A single center experience with two decades of follow-up on patients with hairy cell leukemia.

İLHAN O., Atilla E., Atilla P. A., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPRAK S. K., et al.

53rd Annual Clinical Science Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Symposium on Old Targets, New Drugs - Her2 and MET, Illinois, United States Of America, 2 - 07 June 2017, vol.35

Eski gen yeni fenotip: Ada2 eksikliği

KÖSTEL BAL S., DOĞU E. F., SAHİN S., KUZU I., BOZTUG K., ARSLAN Ö., et al.

3. klinik immünoloji kongresi, Turkey, 12 - 15 April 2017

A Biosimiliar G-CSF filgrastim is as effective as a reference drug however it is not cost effective as supposed to be and by the way no impact on the health care system

YÜKSEL M., PEKCAN G., ŞAHİN U., CİVRİZ BOZDAĞ S., TOPRAK S. K., TOPÇUOĞLU P., et al.

43rdAnnual Meeting of the European Society for Blood and Marrow Transplantation, 26 March - 29 December 2017

The outcome of Haploidentical Hematopoietic Celll Trnasplantations (Haplo HSCT)

ATİLLA E., ECE B., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPRAK S. K., TOPÇUOĞLU P., et al.

43rd Annual Meeting Of EBMT, 26 - 29 March 2017

Peripheral Blood Stem Cell Mobilization and collection from elderly patients 65 years with multipl myeloma: A , single center exprience

CENGİZ SEVAL G., TOPRAK S. K., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., et al.

43rd Annual Meeting Of EBMT, 26 - 29 March 2017

Peripheral blood stem cell mobilization and collection from elderly patients (265 years) with multiple myeloma: A single center experience

CENGİZ SEVAL G., TOPRAK S. K., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., et al.

43rd Annual Meeting of the European Society for Blood and Marrow Transplantation, 26 March 2017

İmkomplet Antikorlar ABO çapraz karşılaştırma uyumsuzluğunu azaltabilirler. Bir başlangıç çalışması

ÖZEN M., ÖZKAN T., YILMAZ S., ÖZER Y., SUNGUROĞLU A., GÜRMAN G., et al.

X. Ulusal Kan Merkezleri ve Transfüzyon Tıbbı Kongresi, Antalya, Turkey, 12 - 16 March 2017

Management and Outcome of Central Nerve System(CNS) Involvement in Acute Lymphoblastic Leukemia

ATİLLA E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., TOPRAK S. K., TOPÇUOĞLU P., ARSLAN Ö., et al.

BMT Tandem Meetings, orlando, United States Of America, 22 - 26 February 2017, vol.23, pp.251

Management and Outcome of Central Nervous System (CNS) Involvement in Acute Lymphoblastic Leukemia (ALL)

ATİLLA E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., TOPRAK S. K., TOPÇUOĞLU P., ARSLAN Ö., et al.

BMT Tandem Meetings, 22 - 26 February 2017

Allogeneic stem cell transplantation for chonic lymphocytic Leukemai

ATİLLA E., ATACA ATİLLA P., pekcan g., İLHAN O., GÜRMAN G., ÖZCAN M., et al.

BMT TANDEM MEETINGS, 22 - 26 February 2017

Catheter Thrombosis in Allogeneic Hematopoietic Stem Cell Transplantation (Allo-HSCT) Recipients

GÜRMAN G., ATİLLA E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPRAK S. K., et al.

BMT Tandem Meetings, 22 - 26 February 2017

Comparison of Reduced Intensity Conditioning (RIC) Regimen and Myeloablative Conditioning (MAC) Regimen in Allogeneic Hematopoietic Stem Cell Transplantation (Allo-HSCT) for Adult Patients with Acute Leukemia

GÜRMAN G., Guloksuz G. A., Atilla E., Atilla P. A., CİVRİZ BOZDAĞ S., YÜKSEL M., et al.

58th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), California, United States Of America, 3 - 06 December 2016, vol.128

Does Hypogammaglobulinemia at Diagosis Effects Survival and Infection Risk in Chronic Lymphocytic Leukemia (CLL)?

Atilla E., Atilla P. A., CİVRİZ BOZDAĞ S., TOPRAK S. K., TOPÇUOĞLU P., İLHAN O., et al.

58th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), California, United States Of America, 3 - 06 December 2016, vol.128

Kronik LenfositikLösemi de Tanı Anında HipogamaglobulinemiSağkalım ve Enfeksiyon Riski Üzerinde Etkili Midir

ATİLLA E., ATACA ATİLLA P., TOPRAK S. K., AKAN H., BEKSAÇ M., İLHAN O., et al.

ULUSAL HEMATOLOJİ 2016, Turkey, 18 - 22 October 2016

AkutLenfositikLösemide ALL SantralSinirSistemi SSS TutulumunaYaklaşım

ATACA ATİLLA P., ATİLLA E., CİVRİZ BOZDAĞ S., TOPRAK S. K., TOPÇUOĞLU P., ARSLAN Ö., et al.

ULUSAL HEMATOLOJİ 2016, Turkey, 18 - 22 October 2016

KRONİK LENFOSİTİK LÖSEMİ DE TANI ANINDAHİPOGAMAGLOBULİNEMİ SAĞKALIM VE ENFEKSİYONRİSKİ ÜZERİNDE ETKİLİ MİDİR

ATACA ATİLLA P., ATİLLA E., PEKCAN G., TOPRAK S. K., TOPÇUOĞLU P., AKAN H., et al.

42. Ulusal Hematoloji Kongresi, Turkey, 19 - 22 October 2016

AKUT MYELOİD LÖSEMİDE FLOW SİTOMETRİ İLEİNDÜKSİYON SONRASI TESPİT EDİLEN CD34 HÜCRESAYISI SAĞKALIM VE RELAPSI ETKİLER

ATİLLA E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., TOPRAK S. K., et al.

42. Ulusal Hematoloji Kongresi, Turkey, 19 - 22 October 2016

AKUT LENFOSİTİK LÖSEMİDE ALL SANTRAL SİNİRSİSTEMİ SSS TUTULUMUNA YAKLAŞIM

ATİLLA E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., TOPRAK S. K., TOPÇUOĞLU P., ARSLAN Ö., et al.

42.Ulusal Hematoloji Kongresi, Turkey, 19 - 22 October 2016

SeyrekbirMalignite Primer Mediastinal Büyük B

ATACA ATİLLA P., ATİLLA E., CENGİZ SEVAL G., PEKCAN G., İLHAN O., ARSLAN Ö., et al.

ULUSAL HEMATOLOJİ 2016, Turkey, 18 - 22 October 2016

SEYREK BİR MALİGNİTE: PRİMER MEDİASTİNALBÜYÜK B HÜCRELİ LENFOMA

ATACA ATİLLA P., ATİLLA E., CENGİZ SEVAL G., PEKCAN G., İLHAN O., ARSLAN Ö., et al.

42.Ulusal Hematoloji Kongresi, Turkey, 18 - 22 October 2016

BEING OVERWEIGHT PRIOR TO ALLOGENEIC STEM CELL TRANSPLANTATION IS RELATED TO BETTER SURVIVAL

ATİLLA E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., AKAN H., et al.

JSH 2016, 13 - 15 October 2016

MANAGEMENT AND OUTCOME OF CENTRAL NERVOUS SYSTEM CNS INVOLVEMENT IN ACUTE LYMPHOBLASTIC LEUKEMIA ALL PRE AND POST TRANSPLANT Conference 21st Congress of the European Hematology AssociationLocation Copenhagen DENMARK

ATACA ATİLLA P., ATİLLA E., CİVRİZ BOZDAĞ S., TOPRAK S. K., TOPÇUOĞLU P., ARSLAN Ö., et al.

21st Congress of the European-Hematology-AssociationLocation: Copenhagen, DENMARK, 9 - 12 June 2016, vol.101

Approach to Hairy Cell Leukemia HCL 31 years of Experience

KIRCALI E., ATACA ATİLLA P., ATİLLA E., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., et al.

EHA 2016, 9 - 12 June 2016

Age as a dicision factor for doing autuologous stem cell transplantation in fit patients with myeloma and lymphoma ASCO Annual Meeting J Clin Oncol 34 2016 suppl abstr e 19001

İLHAN O., ATİLLA E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., et al.

ASCO, 3 - 07 June 2016

THE EFFICACY OF TYROSINE KINASE INHIBITORS WITH STEROID IN Ph ACUTE LYMPHOBLASTIC LEUKEMIA

GÜRMAN G., MERTER M., ATİLLA E., ŞAHİN U., TOPÇUOĞLU P., ARSLAN Ö., et al.

ASCO 2016, ABD, 3 - 07 June 2016

Age as a decision factor for doing autologous stem cell transplantation in fit patients with myeloma and lymphoma Subcategory

İLHAN O., ATİLLA E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., et al.

ASCO 2016, ABD, 3 - 07 June 2016

Age is not a Significant Factor in Decision of Doing Autologous Stem Cell Transplantation in Fit Patients with Myeloma and Lymphoma!

ATİLLA E., ATACA ATİLLA P., TOPRAK S. K., YÜKSEL M., TOPÇUOĞLU P., ÖZCAN M., et al.

ASCO 2016, 3 - 07 June 2016

Are Age and JAK2V617F Mutation Related to Trombosis in Chronic Myeloproliferative Diseases

ATİLLA E., ATACA ATİLLA P., TOPRAK S. K., KAYGUSUZ G., KUZU I., CİVRİZ BOZDAĞ S., et al.

24th Biennial International Congress on Thrombosis, 4 - 07 May 2016

A rare manifestation: Primary mediastinal large-b cell lymphoma.

Atilla E., Ataca P., İLHAN O., ARSLAN Ö., GÜRMAN G., ÖZCAN M.

Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America, 3 - 07 June 2016, vol.34

Poliradikülopati Bulguları ile Nüks Olan Bir ALL Olgusu

ERDOĞAN S., AKSUN Z., hüseynova s., ARSLAN Ö., ŞENER H. Ö.

32. Ulusal Klinik Nörofizyoloji EEG-EMG Kongresi, Turkey, 27 April - 01 May 2016

The efficacy of tyrosine kinase inhibitors with steroid in phi- acute lymphoblastic leukemia.

GÜRMAN G., Merter M., Atilla E., Sahin U., TOPÇUOĞLU P., ARSLAN Ö., et al.

Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America, 3 - 07 June 2016, vol.34

Poliradikülopati Bulguları İle Nüks Olan Bir ALL Olgusu

Erdoğan S., Özaydın Aksun Z., Hüseynova S., Arslan Ö., Şener H. Ö.

32. Ulusal Klinik Nörofizyoloji EEG-EMG Kongresi, Muğla, Turkey, 27 April - 01 May 2016, pp.66

Age as a dicision factor for doing autuologous stem cell transplantation in fit patients with myeloma and lymphoma

İLHAN O., ATİLLA E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., TOPRAK S. K., TOPÇUOĞLU P., et al.

ASCO, 3 - 07 June 2016

42nd Annual Meeting of the European Society for Blood and Marrow Transplantation

TOPÇUOĞLU P., ATİLLA E., CİVRİZ BOZDAĞ S., YÜKSEL M., ARSLAN Ö., BEKSAÇ M., et al.

42nd Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, 3 - 06 April 2016

prognosis of acute leukemia patients in active disease undergoing allogeneic hematopoietic stem cell transplantation

ŞAHİN U., MERTER M., ateşağoğlu b., erdal h., CİVRİZ BOZDAĞ S., TOPRAK S. K., et al.

41.ebmt meeting, 22 - 25 March 2015

HAİRY CELL LÖSEMİ HCL VAKALARIMIZ TEKMERKEZ DENEYİMİ

Kırcalı E., ATACA P., ATİLLA E., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., et al.

41.Ulusal Hematoloji Kongresi, Turkey, 21 - 24 October 2015

DONÖR KAN HEMOGLOBİN SEVİYESİ ÖLÇÜMÜ İÇİNKULLANILAN İKİ YÖNTEMİN KARŞILAŞTIRILMASI

Özdemir Z. N., ATACA P., Özer Y., ARSLAN Ö., TOPÇUOĞLU P.

41.Ulusal Hematoloji Kongresi, Turkey, 21 - 24 October 2015

Clinical Allogeneic Transplantation Acute and Chronic GVHD Immune Reconstitution

GÜRMAN G., ATACA P., ATİLLA E., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., et al.

57th ASH Annual Meeting & Exposition, 5 - 08 December 2015

Is Initial CD3+T Cell Dose in Donor Lymphocyte Infusion for Relapsed Hematological Malignancies a Prognostic Determinant?

Atilla E., Ataca P., TOPRAK S. K., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., et al.

57th Annual Meeting of the American-Society-of-Hematology, Florida, United States Of America, 5 - 08 December 2015, vol.126

Positive Impact of Chronic Graft-Versus Host Disease on Survival in 928 Allogeneic Hematopoietic Stem Cell Transplant Recipients

GÜRMAN G., Ataca P., Atilla E., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., et al.

57th Annual Meeting of the American-Society-of-Hematology, Florida, United States Of America, 5 - 08 December 2015, vol.126

Comparison of Two Different Doses of Corticosteroid Premedication for Antithymocyte Globulin in Allogeneic Hematopoietic Stem Cell Transplantation

Merter M., Atilla E., Sahin U., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., et al.

57th Annual Meeting of the American-Society-of-Hematology, Florida, United States Of America, 5 - 08 December 2015, vol.126

Allojeneik Hematopoietik Kök Hücre Nakli AHKHN Hastalarında Gelişen Üst ve Alt Solunum Yolları Viral Enfeksiyonları

ATİLLA E., ATACA P., ŞAHİN D., DOLAPÇI G. İ., TEKELİ F. A., CİVRİZ BOZDAĞ S., et al.

Febril Nötropeni Simpozyumu, Turkey, 28 - 30 November 2015

Ph Negatif ALL Hastalarında Allojenik Kök Hücre Nakli Öncesi Tedavilerin Klinik Seyir ile İlişkisi

NARLI ÖZDEMİR Z., EKİN K., ATACA P., ATİLLA E., TOPÇUOĞLU P., CİVRİZ BOZDAĞ S., et al.

41. Ulusal Hematoloji Kongresi, Turkey, 21 - 24 October 2015

Kronik Lenfositik Lösemide Allojeneik Kök Hücre Nakli Deneyimi

PEKCAN G., ATİLLA E., ATACA P., ARSLAN Ö.

41. Ulusal Hematoloji Kongresi, Turkey, 21 - 24 October 2015

Hairy Cell Lösemi HCL vakalarımız Tek Merkez Deneyimi

KIRCALI E., ATACA P., ATİLLA E., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., et al.

41. Ulusal Hematoloji Kongresi, Turkey, 21 - 24 October 2015

ALLOJENEİK HEMATOPOİETİK KÖK HÜCRENAKLİNDE İKİ FARKLI ANTİTİMOSİTGLOBULİN PREMEDİKASYON PROTOKOLÜNÜNKARŞILAŞTIRILMASI

MERTER M., ŞAHİN U., Ateşağaoğlu B., TOPRAK S. K., YÜKSEL M., TOPÇUOĞLU P., et al.

41.Ulusal Hematoloji Kongresi, Turkey, 21 - 24 October 2015

ALLOJENEİK KÖK HÜCRE TRANSPLANTASYONHASTASINDA KRONİK GRAFT VERSUS HOSTHASTALIĞININ GENEL SAĞKALIM ÜZERİNE ETKİSİ

ATİLLA E., ATACA P., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., DEMİRER T., et al.

41. Ulusal Hematoloji Kongresi, Turkey, 21 - 24 October 2015

MYELODİSPLASTİK SENDROMDA MDS ALLOJENEİKHEMATOPOİETİK KÖK HÜCRE NAKLİ

ATİLLA E., ATACA P., BEKSAÇ M., ÖZCAN M., ARSLAN Ö., İLHAN O., et al.

41.Ulusal Hematoloji Kongresi, Turkey, 21 - 24 October 2015

ALLOJENEİK HEMATOPOİETİK KÖK HÜCRE NAKLİ YAPILAN HASTALARDA ANTİ HLA ANTİKORLARI İLE ENGRAFMAN YETMEZLİĞİ İLİŞKİSİ TEK MERKEZ DENEYİMİ

MERTER M., ŞAHİN U., ateşağaoğlu b., TOPRAK S. K., YÜKSEL M., TOPÇUOĞLU P., et al.

41.Ulusal Hematoloji Kongresi, Turkey, 21 - 23 October 2015

Chronic Myeloproliferative Disease in Geriatric Patients Single Center Experience

TOPRAK S. K., ATİLLA E., ATACA P., BEKSAÇ M., konuk n., TOPÇUOĞLU P., et al.

77th Annual Meeting of the Japanese Society of Hematology, 16 - 18 October 2015

Is Allogeneic Stem Cell Transplantation Safe in MDS

TOPÇUOĞLU P., ATİLLA E., ATACA P., BEKSAÇ M., ÖZCAN M., ARSLAN Ö., et al.

77th Annual Meeting of Japanese Society of Hematology, 16 - 18 October 2015

Allogeneic Stem Cell Transplant Safe in MDS

TOPÇUOĞLU P., ATİLLA E., ATACA P., BEKSAÇ M., ÖZCAN M., ARSLAN Ö., et al.

77th Annual Meeting of the Japanese Society of Hematology, October 16-18, 2015, Kanazawa, Japan., 1 - 03 October 2015

Is Allogeneic Stem Cell Transplant Safe in MDS

TOPÇUOĞLU P., ATİLLA E., ATACA P., BEKSAÇ M., ÖZCAN M., ARSLAN Ö., et al.

77th Annual Meeting of the Japanese Society of Hematology, Oral Presentation, 16 - 18 October 2015

Myeloproliferative Disease in Geriatric Patients Single Center Experience

TOPRAK S. K., ATİLLA E., ATACA P., BEKSAÇ M., Konuk N., TOPÇUOĞLU P., et al.

77th Annual Meeting of the Japanese Society of Hematology, 16 - 19 October 2015

Azatitidine in combination with ATRA valproic acid in elderly AML patient

ÖZCAN M., CİVRİZ BOZDAĞ S., BERNA A., ATİLLA E., ATACA P., TOPRAK S. K., et al.

ASCO 2015, 29 May - 02 June 2015

CML leukemic stem cell CML LCS Its existence in patients who achieved cytogenetic molecular response under treatment of TKI

İLHAN O., USLU A., TOPRAK S. K., TOPÇUOĞLU P., ATİLLA E., ATACA P., et al.

ASCO 2015, 29 - 02 May 2015

Extramedullary Relapse of Acute Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation Allo HSCT A Single Center Experience 41st Annual Meeting of the European Society for Blood and

MERTER M., uğur ş., gündüz m., ATİLLA E., CİVRİZ BOZDAĞ S., TOPRAK S. K., et al.

(Allo-HSCT): A Single Center Experience. 41st Annual Meeting of the European Society for Blood and Marrow Transplantation, Istanbul, 22-25 Mayıs 2015., 22 - 25 May 2015

Allogeneic Stem Cell Transplantation for Hodgkin and non Hodgkin Lymphoma

ATACA P., ATİLLA E., CİVRİZ BOZDAĞ S., TOPRAK S. K., TOPÇUOĞLU P., ARSLAN Ö., et al.

5th International Congress on Lymphoma Leukemia Myeloma, İstanbul, Turkey, 21-23 May 2015. Turkish Society of Hematology, Proceedings & Abstract Book, abstract # 0109, poster # PS-101 pp 175., 21 - 23 May 2015

AUTOLOGOUS STEM CELL TRANSPLANTATION IN ELDERLY PATIENTS 60 YEARS WITH MYELOMA OR LYMPHOMA

ATİLLA E., GÜNDÜZ M., ATACA P., CİVRİZ BOZDAĞ S., TOPRAK S. K., MELTEM K. Y., et al.

5th International Congress on Lymphoma Leukemia Myeloma, İstanbul, Turkey, 21 - 23 May 2015

Azacitidine in combination with ATRA, valproic acid in elderly AML patients.

ÖZCAN M., CİVRİZ BOZDAĞ S., Atesagaoglu B., Atilla E., Ataca P., TOPRAK S. K., et al.

Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Illinois, United States Of America, 29 May - 02 June 2015, vol.33